0001104659-20-131774.txt : 20201203 0001104659-20-131774.hdr.sgml : 20201203 20201203060754 ACCESSION NUMBER: 0001104659-20-131774 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201201 FILED AS OF DATE: 20201203 DATE AS OF CHANGE: 20201203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BLUTT MITCHELL J MD CENTRAL INDEX KEY: 0001097955 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39635 FILM NUMBER: 201365631 MAIL ADDRESS: STREET 1: 1370 AVENUE OF THE AMERICA STREET 2: SUITE 3301 CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Consonance-HFW Acquisition Corp. CENTRAL INDEX KEY: 0001824893 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 981556622 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 PALMER SQUARE STREET 2: SUITE 305 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: (609) 921-2333 MAIL ADDRESS: STREET 1: 1 PALMER SQUARE STREET 2: SUITE 305 CITY: PRINCETON STATE: NJ ZIP: 08540 4 1 a4.xml 4 X0306 4 2020-12-01 0 0001824893 Consonance-HFW Acquisition Corp. CHFW 0001097955 BLUTT MITCHELL J MD C/O CONSONANCE-HFW ACQUISITION CORP. 1 PALMER SQUARE, SUITE 305 PRINCETON NJ 08540 1 0 0 0 Class A Ordinary Shares 2020-12-01 4 P 0 24000 A 434000 I See Footnote Warrant 11.50 2020-12-01 4 P 0 8000 A Class A Ordinary Shares 8000 144667 I See Footnote Includes securities underlying the 24,000 private placement units of the Issuer purchased by Consonance Life Sciences (the "Sponsor") for $10.00 per private placement unit. The private placement units were purchased in a private placement upon the exercise in full of the over-allotment option granted to the underwriters to purchase additional shares in the Issuer's initial public offering. Each unit consists of one share of Class A ordinary share and one-third of one warrant, with each whole warrant entitling the holder to purchase one share of Class A ordinary share at $11.50 per share. The Sponsor is the record holder of the shares and warrants reported herein. The Sponsor is governed by a board of managers consisting of Mitchell J. Blutt, Benny Soffer and Kevin Livingston. As such, Mitchell J. Blutt, Benny Soffer and Kevin Livingston have voting and investment discretion of the shares held by the Sponsor and may be deemed to have shared beneficial ownership of the shares held by the Sponsor. Each of Mitchell J. Blutt, Benny Soffer and Kevin Livingston disclaims beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly. The warrants will become exercisable on the later of (a) 30 days after the completion of the Issuer's initial business combination or (b) 12 months from the closing of the Issuer's initial public offering. The warrants will expire five years after the completion of the Issuer's initial business combination. Includes 8,000 warrants underlying the units referred to in footnote 1. Kevin Livingston, Attorney-in-Fact 2020-12-03